PolyPid Ltd. (PYPD) Form 6-K — Aug 12, 2026
PolyPid reported a net loss of $15.6 million for the six months ended June 30, 2026, improved from $18.2 million a year earlier, ending the period with $6.6 million in cash, $5.4 million in shareholders' equity, and no debt after fully repaying its Kreos loan in May 2026. The interim financial statements carry a substantial-doubt going-concern warning: the company states it has not raised the funding needed to continue operations for at least one year, though management expects existing cash plus a $15 million Azurity milestone payment expected in September 2026 to fund operations for at least twelve months.
Key figures
- Total Debt
- 0
- Total Assets
- 15234000
- Cash Position
- 6563000
- Shares Outstanding
- 20311766
- Net loss h1 2025
- 18245000
- Accumulated deficit
- 317077000
- Rnd expense h1 2026
- 11881000
- Operating loss h1 2025
- 16982000
- Operating loss h1 2026
- 15609000
- Atm shares sold h1 2026
- 796581
- Azurity upfront payment
- 15000000
- Kreos loan fully repaid
- 2026-05-04
- Atm proceeds h1 2026 net
- 3703000
- Iia grants received to date
- 4898000
- Azurity additional milestones
- over $290 million
- Shares outstanding dec 31 2025
- 18204002
- Azurity nda acceptance milestone
- 15000000
- Shareholders equity june 30 2026
- 5388000
- Potential dilutive shares excluded
- 9332676
- Net cash used in operating activities h1 2026
- 13835000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.